Venous thromboembolism in uterine cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 5, 2011, Pages 870-876

  Rodriguez, Anne O ^a,b   Gonik, Abby M ^a   Zhou, Hong ^b   Leiserowitz, Gary S ^a   White, Richard H ^b  

^a Division of Gynecologic Oncology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Deep vein thrombosis; Endometrial cancer; Pulmonary embolus; Uterine cancer; Uterine sarcoma; Venous thromboembolism

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; UTERUS CANCER; VENOUS THROMBOEMBOLISM;

EID: 82955197320     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31821a367e     Document Type: Article

References (21)

1. Chisaka H, Utsunomiva H, Okamura K, et al. Pulmonary thromboembolism following gynecologic surgery and cesarean section. Int J Gynaecol Obstet. 2004;84:47-53. (Pubitemid 38064142)
2. Martino MA, Borges E, Williamson E, et al. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet Gynecol. 2006;107:666-671.
3. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcomeYbased prospective study on venous thromboembolism after cancer surgery: The @RISTOS project. Ann Surg. 2006;243:89-95. (Pubitemid 43054059)
4. Rodriguez AO, Wun T, Chew H, et al. Venous thromboembolism in ovarian cancer. Gynecol Oncol. 2007;105:784-790. (Pubitemid 46734211)
5. Kwong SL, Perkins CL, Morris CR, et al. Cancer in California: 1988-1999. Sacramento, CA: Department of Health Services, Cancer Surveillance Section; 2001.
6. California Office of Statewide Health Planning and Development. Patient Discharge Data File Documentation: Full Calendar Years 1990-2001. Sacramento, CA: Office of Statewide Health Planning and Development; 2006.
7. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds). SEER Summary Staging Manual-2000, National Cancer Institute, National Institutes of Health Pub no. 01-4569, Bethesda, MD, 2001. Available at: Http://seer.cancer. gov/tools/ssm/breast-femgen. pdf. Accessed August 23, 2010.
8. White RH, Garcia M, Sadeghi B, et al. Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res. 2010;126:61-67.
9. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. Available at: Http://www.hcup-us.ahrq.gov/ toolssoftware/ comorbidity/comorbidity.jsp. Accessed March 5, 2008.
10. Uitenbroek DG. SISA. Southampton, UK: DG Uitenbroek; 1997. Available at: Http://home.clara.net/sisa/binomial.htm. Accessed September 10, 2008.
11. Blom JW. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715-722. (Pubitemid 40216041)
12. Rickles FR, Levine MN. Epidemiology of thrombosis in cancer. Acta Haematol. 2001;106:6-12. (Pubitemid 32830510)
13. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166:458-464.
14. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 1983;62:14-31. (Pubitemid 13070586)
15. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11-S17.
16. Trousseau A. Phlegmasia Alba Dolens. Clinique Medicale de l'Hotel-Dieu de Paris. Vol. 3. London, UK: New Sydenham Society. 1865:94.
17. Boccaccio C, Comoglio PM. A functional role for hemostasis in early cancer development. Cancer Res. 2005;65:8579-8582. (Pubitemid 41377338)
18. Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: Implications for tumor progression and angiogenesis. Blood. 2005;105: 1734-1741. (Pubitemid 40223697)
19. von Templehoff GF, Harenberg J, Niemann F, et al. Effect of low molecular weight heparin versus unfractionated heparin on cancer survival following breast and pelvic surgery: A prospective randomized, double-blind trial. Int J Oncol. 2000;16:815.
20. Kakkar AK, Levine MN, Kadziola Z, et al. Low molecular weight heparin, therapy with dalteparin and survival in advanced cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol. 2004;21:1944-1948. (Pubitemid 41095187)
21. Lee AYY, Rickles FR, Julian JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23:2123-2129. (Pubitemid 46218703)